+499.5%
MRNA vs LYV
+6.6%
+492.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LYV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.2% | 0.0% | -0.8% |
| 7D | +5.5% | -4.5% | +10.0% | +8.5% |
| 30D | +158.7% | -5.5% | +164.2% | +169.1% |
| 3M | +182.1% | +7.8% | +174.4% | +189.4% |
| 6M | +151.8% | +9.4% | +142.4% | +156.4% |
| YTD | +393.6% | +21.8% | +371.8% | +400.7% |
| 1Y | +499.5% | +6.5% | +493.0% | +485.4% |
| All | +499.5% | +6.6% | +492.8% | +485.4% |
Cumulative growth
Daily Returns
Daily percentage return beside LYV.
Daily Out/Under-Performance
Portfolio return minus LYV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LYV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LYV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling